These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7016901)

  • 1. Selective medium for isolation of Clostridium botulinum from human feces.
    Dezfulian M; McCroskey LM; Hatheway CL; Dowell VR
    J Clin Microbiol; 1981 Mar; 13(3):526-31. PubMed ID: 7016901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants.
    Mills DC; Midura TF; Arnon SS
    J Clin Microbiol; 1985 Jun; 21(6):947-50. PubMed ID: 3891773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and enumeration of Clostridium botulinum by direct inoculation of infant fecal specimens on egg yolk agar and Clostridium botulinum isolation media.
    Glasby C; Hatheway CL
    J Clin Microbiol; 1985 Feb; 21(2):264-6. PubMed ID: 3882751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and differential medium for detecting Clostridium botulinum.
    Silas JC; Carpenter JA; Hamdy MK; Harrison MA
    Appl Environ Microbiol; 1985 Oct; 50(4):1110-1. PubMed ID: 2867740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective medium for isolation of Clostridium butyricum from human feces.
    Popoff MR
    J Clin Microbiol; 1984 Sep; 20(3):417-20. PubMed ID: 6490827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective isolation and rapid identification of Clostridium botulinum types A and B by toxin detection.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1985 Feb; 21(2):231-3. PubMed ID: 3882748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective and differential medium for isolation of Clostridium difficile.
    George WL; Sutter VL; Citron D; Finegold SM
    J Clin Microbiol; 1979 Feb; 9(2):214-9. PubMed ID: 429542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cultural and physiological characteristics and antimicrobial susceptibility of Clostridium botulinum isolates from foodborne and infant botulism cases.
    Dezfulian M; Dowell VR
    J Clin Microbiol; 1980 Jun; 11(6):604-9. PubMed ID: 7000811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a combined selection and enrichment PCR procedure for Clostridium botulinum Types B, E, and F and its use to determine prevalence in fecal samples from slaughtered pigs.
    Dahlenborg M; Borch E; Rådström P
    Appl Environ Microbiol; 2001 Oct; 67(10):4781-8. PubMed ID: 11571185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral botulism at dairy farms in Schleswig Holstein, Germany: prevalence of Clostridium botulinum in feces of cows, in animal feeds, in feces of the farmers, and in house dust.
    Krüger M; Große-Herrenthey A; Schrödl W; Gerlach A; Rodloff A
    Anaerobe; 2012 Apr; 18(2):221-3. PubMed ID: 22200452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis and laboratory diagnosis of three cases with infantile botulism caused by
    Ge XS; Sun QJ; Xu XF; Liu S; Huang Y; Gao PY; Liu ZN; Peng XJ; Liu Y; Peng XY; Wu CD
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):499-502. PubMed ID: 32521963
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitation of Clostridium botulinum organisms and toxin in the feces of an infant with botulism.
    Paton JC; Lawrence AJ; Manson JI
    J Clin Microbiol; 1982 Jan; 15(1):1-4. PubMed ID: 6764763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism.
    McCroskey LM; Hatheway CL; Fenicia L; Pasolini B; Aureli P
    J Clin Microbiol; 1986 Jan; 23(1):201-2. PubMed ID: 3517043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of An Innovative and Quick Method for the Isolation of
    Le Gratiet T; Poezevara T; Rouxel S; Houard E; Mazuet C; Chemaly M; Maréchal CL
    Toxins (Basel); 2020 Jan; 12(1):. PubMed ID: 31936866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of human pathogenic Clostridium botulinum among healthy dairy animals: an emerging public health hazard.
    Abdel-Moein KA; Hamza DA
    Pathog Glob Health; 2016; 110(1):25-9. PubMed ID: 27077311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism.
    Paton JC; Lawrence AJ; Steven IM
    J Clin Microbiol; 1983 Jan; 17(1):13-5. PubMed ID: 6338033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common mesophilic anaerobes, including Clostridium botulinum and Clostridium tetani, in 21 soil specimens.
    Smith LD
    Appl Microbiol; 1975 May; 29(5):590-4. PubMed ID: 238468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examination of feces and serum for diagnosis of infant botulism in 336 patients.
    Hatheway CL; McCroskey LM
    J Clin Microbiol; 1987 Dec; 25(12):2334-8. PubMed ID: 3323228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a new, bismuth-iron-sulfite-cycloserine agar for isolation of Clostridium perfringens with the tryptose-sulfite-cycloserine and blood agars.
    Gubash SM; Ingham L
    Zentralbl Bakteriol; 1997 Feb; 285(3):397-402. PubMed ID: 9084113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.
    Swenson JM; Thornsberry C; McCroskey LM; Hatheway CL; Dowell VR
    Antimicrob Agents Chemother; 1980 Jul; 18(1):13-9. PubMed ID: 6998374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.